BioCryst Pharmaceuticals Inc.

Last updated September 27, 2026

Organization details

Legal name
BioCryst Pharmaceuticals Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Durham
Headquarters state / province
North Carolina
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BCRX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000882796
EIN
62-1413174
Wikidata ID
Q4914611

Board of directors

Chief executives

Jon P. Stonehouse · President & CEO
Dates unknown

Director election results

Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 4 other boards. 4 are in the same sector.

Network of BioCryst Pharmaceuticals Inc.'s board connections Aclaris Therapeutics Inc. Aclaris Therapeutics I... Fortrea Holdings Inc. Fortrea Holdings Inc. Precigen Inc. Precigen Inc. ProQR Therapeutics N.V. ProQR Therapeutics N.V... Machelle Sanders Machelle Sanders Steven Frank Steven Frank Theresa Heggie Theresa Heggie Vincent Milano Vincent Milano BioCryst Pharmaceuticals I...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$4,135,622
10 sales by 4 insiders
Date Insider Transaction Shares Price Value
Aug 31, 2026 Steven Frank Director Grant or award +1,288 $9.70 $12,494
Aug 31, 2026 Amy E. McKee Director Grant or award +644 $9.70 $6,247
Aug 31, 2026 Vincent Milano Director Grant or award +1,159 $9.70 $11,242
Aug 31, 2026 Jill C. Milne Director Grant or award +1,288 $9.70 $12,494
Aug 31, 2026 Jon P. Stonehouse Director Grant or award +644 $9.70 $6,247
Jun 11, 2026 Jill C. Milne Director Grant or award +15,294 — —
Jun 11, 2026 Steven K. Galson Director Grant or award +15,294 — —
Jun 11, 2026 Alan G. Levin Director Grant or award +15,294 — —
Jun 11, 2026 Steven Frank Director Grant or award +15,294 — —
Jun 11, 2026 Machelle Sanders Director Grant or award +15,294 — —
Jun 11, 2026 Vincent Milano Director Grant or award +15,294 — —
Jun 11, 2026 Jon P. Stonehouse Director Grant or award +15,294 — —
Jun 11, 2026 Amy E. McKee Director Grant or award +15,294 — —
Jun 11, 2026 Theresa Heggie Director Grant or award +15,294 — —
May 29, 2026 Jill C. Milne Director Grant or award +1,262 $8.91 $11,244

Organizations in the same sector, closest in location and size first.

Questions about BioCryst Pharmaceuticals Inc.

Who is the CEO of BioCryst Pharmaceuticals Inc.?

Jon P. Stonehouse is BioCryst Pharmaceuticals Inc.'s President & CEO.

How many directors are on BioCryst Pharmaceuticals Inc.'s board?

BioCryst Pharmaceuticals Inc.'s board has 14 directors: Alan G. Levin, Amy E. McKee, George B. Abercrombie, Jill C. Milne, Jon P. Stonehouse, Kenneth B. Lee Jr., Machelle Sanders, Nancy J. Hutson, Robert Alexander Ingram, Steve Aselage and 4 others.

Are BioCryst Pharmaceuticals Inc. insiders buying or selling shares?

Over the last 12 months, BioCryst Pharmaceuticals Inc. insiders made no open-market purchases and sold $4.1 million of shares in 10 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="biocryst-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.